The American Urological Association (AUA) remains a trailblazer in delivering innovative, evidence-driven educational content for urologists and urologic healthcare providers around the world. Through its Annual Meeting and various educational initiatives throughout the year, the AUA consistently sets the bar for excellence in urologic education. The 2025 AUA Annual Meeting, taking place in Las Vegas from April 26-29, will bring together urologists from all over the globe. Now in its 120th year, this event is the largest gathering of its kind, offering exclusive access to cutting-edge research, updated guidelines, and the latest breakthroughs in urologic care. Given the vast array of opportunities at the meeting, it’s no surprise that attendees frequently report that the insights gained have a significant positive impact on their professional practices.

To ensure your spot at this prestigious event, we strongly encourage you to register as soon as possible by clicking this link. Early registration will allow you to secure accommodations, access travel details, plan your schedule, and guarantee your participation in educational and networking events before they reach capacity.

Below, we’ve compiled a list of prostate cancer-focused sessions at #AUA2025, organized chronologically for your convenience.

AUA2025 Spotlight: PARP-Inhibitor Combination Treatments for the Urologic Care Team

  • Date: Friday, April 25, 2025
  • Time: 7:00 AM to 8:00 AM (US/Pacific)
  • Location: Venetian I, Forum
    • This session will explore the role of PARP-inhibitors in the treatment of castration-resistant prostate cancer (CRPC), offering valuable insights for the urologic care team in this rapidly evolving field. It precedes the full-day program on advanced prostate cancer treatment and brings together the latest evidence for integrating PARP-inhibitor combination therapies into clinical practice.

Fundamentals of Prostate MRI and Transperineal Interventions

  • Date: Friday, April 25, 2025
  • Time: 8:00 AM to 3:00 PM (US/Pacific)
  • Location: Expo Meeting Room 103, Hands-on Skills Training
    • This full-day hands-on course will cover essential skills in interpreting prostate MRI, a crucial aspect of biopsy, local staging, and surgical planning. The session will also highlight the use of transperineal biopsy techniques to reduce infection risks while improving the diagnosis of clinically significant prostate cancer. Attendees will gain practical experience and knowledge from leading experts to enhance their confidence in offering these procedures in clinical practice.

Evolving Landscape of Advanced Prostate Cancer: A Guidelines and Case-Based Discussion Presented by the AUA in partnership with the Society of Urologic Oncology (SUO)

  • Date: Friday, April 25, 2025
  • Time: 8:15 AM to 5:15 PM (US/Pacific)
  • Location: Venetian G
    • This in-depth, interactive course will equip healthcare professionals with the necessary knowledge to manage advanced prostate cancer. Through a detailed exploration of the latest guidelines, treatments, and emerging therapies, participants will better understand the complexities of managing this condition. The course will emphasize multidisciplinary care, genetic testing, next-generation imaging, and treatment sequencing, with case studies and group discussions for practical application.

Expert Panel Discussion: Real-World Head-to-Head Data in Advanced Prostate Cancer | Sponsored by: Johnson & Johnson

  • Date: Saturday, April 26, 2025
  • Time: 12:30 PM to 1:15 PM (US/Pacific)
  • Location: S&T Hall, Booth #2001, Product Theater
    • This expert-led session will focus on the TITAN clinical study of ERLEADA®, reviewing its efficacy, safety, and the real-world data behind its use. The panel will discuss the clinical relevance of these findings in treating advanced prostate cancer, offering insights into current and future treatment strategies.

Integration of Biomarkers, MRI, and PSMA PET Imaging Into the Management of Prostate Cancer

  • Date: Saturday, April 26, 2025
  • Time: 2:00 PM to 4:00 PM (US/Pacific)
    • This session will delve into the use of biomarkers and molecular imaging in prostate cancer management. Participants will learn how to apply PSMA PET/CT imaging in staging and treatment planning, including its role in identifying metastatic disease and assessing organ-confined prostate cancer. The course will also address how to integrate these technologies into individualized treatment strategies.

Essentials of Focal Therapy for Localized Prostate Cancer: From Clinical Trials to Clinical Practice

  • Date: Saturday, April 26, 2025
  • Time: 4:00 PM to 6:00 PM (US/Pacific)
  • Location: Titian 2304
    • This course will provide a foundational understanding of focal therapy for localized prostate cancer, reviewing the evidence and clinical trials that support its use. Participants will engage in case-based discussions to assess patient selection, treatment outcomes, and the role of quality of life assessments in managing patients. Emphasis will be placed on enhancing patient-physician communication and decision-making.

AUA Guideline: Salvage Therapy for Prostate Cancer

  • Date: Sunday, April 27, 2025
  • Time: 7:30 AM to 9:30 AM (US/Pacific)
  • Location: Titian 2302
    • This session will review the 2024 AUA guidelines on salvage therapy for prostate cancer, focusing on risk stratification and advanced imaging techniques. The course will cover salvage radiation therapy, the use of androgen deprivation therapy, and the application of next-generation imaging for managing biochemical recurrence. Attendees will gain practical insights into optimizing cancer control based on patient and tumor factors.

AUA Guidelines on Early Detection of Prostate Cancer: Maximizing Benefits, Minimizing Harm

  • Date: Monday, April 28, 2025
  • Time: 1:30 PM to 3:30 PM (US/Pacific)
  • Location: Titian 2302
    • This course will focus on the evolving landscape of prostate cancer detection, examining the latest guidelines and screening methods. Attendees will explore PSA testing, the use of biomarkers, and advances in biopsy techniques, including MRI-targeted biopsies. The session will provide an evidence-based approach to diagnosing clinically significant prostate cancer while minimizing harm and improving patient experience.

AUA Advanced Prostate Cancer Course

  • Date: Tuesday, April 29, 2025
  • Time: 7:30 AM to 9:30 AM (US/Pacific)
  • Location: Veronese 2401
    • This comprehensive course will focus on the management of advanced prostate cancer based on the latest AUA/SUO guidelines. Topics will include risk stratification, PET imaging, treatment intensification for newly diagnosed advanced prostate cancer, and the use of PARP inhibitors in metastatic CRPC. The course will also address the latest advances in precision medicine and emerging therapies for CRPC, with a focus on treatment sequencing and combination therapies.

The AUA2025 is set to be an enriching and informative event. We recommend clicking here to explore the comprehensive list of topics and sessions that will be covered at this significant event. Don’t miss the opportunity to expand your expertise — register today.

Sign up for alerts and stay informed on the latest published guidelines and stay tuned for our recap post the conference.


Copyright © 2025 Guideline Central, All Rights Reserved.